Related Experiment Video
Updated: Apr 14, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
VPS34 in Autophagy, Cancer, and Cancer Therapy.
Elisabetta Bartolini1,2, Bassam Janji1, Ruize Gao1
1Tumor Immunotherapy and Microenvironment (TIME) Group, Department of Cancer Research, Luxembourg Institute of Health, 6A, Rue Nicolas-Ernest Barblé, L-1210 Luxembourg, Luxembourg.
Vacuolar Protein Sorting 34 (VSP34) regulates autophagy, a key cellular process. Inhibiting VSP34 can enhance anti-tumor immunity, suggesting its potential in cancer immunotherapy.
Area of Science:
- Cellular Biology
- Molecular Biology
- Cancer Research
Background:
- Autophagy is a vital cellular process for maintaining homeostasis under stress.
- Vacuolar Protein Sorting 34 (VSP34) is essential for autophagy initiation and progression.
- The VSP34-autophagy pathway has context-dependent roles in cancer, promoting survival in established tumors.
Purpose of the Study:
- To review the molecular functions and regulation of VSP34 in autophagy.
- To explore the link between VSP34, tumor microenvironment modulation, and cancer immunotherapy.
- To highlight the potential of VSP34 inhibition in enhancing anti-tumor immune responses.
Main Methods:
- Literature review of VSP34 functions in cellular homeostasis and cancer.
- Analysis of VSP34's role in modulating the tumor microenvironment (TME).
- Examination of VSP34's impact on immune cell infiltration and anti-tumor immunity.
Main Results:
- VSP34 influences autophagy, cGAS-STING, and STAT1 pathways, shaping the TME.
- VSP34 inhibition can trigger an interferon response, increasing CD8+ T and NK cell infiltration.
- This suggests VSP34 inhibition can convert "cold" tumors into "hot" tumors, improving immunotherapy efficacy.
Conclusions:
- The VSP34-autophagy axis is a critical regulator in cancer progression and immune evasion.
- Targeting VSP34 presents a promising strategy to enhance the effectiveness of cancer immunotherapies.
- Combining VSP34 inhibitors with existing immunotherapies could overcome treatment resistance and improve patient outcomes.
Related Concept Videos
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

